We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bellevue Healthcare Trust Plc | LSE:BBH | London | Ordinary Share | GB00BZCNLL95 | RED ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.20 | 0.14% | 141.20 | 141.20 | 141.40 | 141.40 | 140.40 | 141.20 | 2,010,166 | 16:35:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | -107.16M | -121.04M | -0.2675 | -5.29 | 637.89M |
Bellevue Healthcare Trust plc |
|
|
|
Transaction in own shares |
|
|
|
Bellevue Healthcare Trust plc (the "Company") announces that it purchased the following number of its ordinary shares of 1 penny each on the London Stock Exchange through J.P. Morgan Securities plc. |
|
|
|
Date of purchase: |
21 November 2024 |
Number of ordinary shares purchased: |
40,060 |
Trading venue |
LSE |
Average price paid per share: |
133.52p |
|
|
The Company intends to hold the purchased shares in treasury. |
|
|
|
Following the above transaction, the Company holds 31,361,361 of its ordinary shares in treasury and has 447,625,835 ordinary shares in issue (excluding treasury shares). |
|
|
|
The Company's LEI is: 213800HQ3J3H9YF2UI82 |
|
|
|
Enquiries: |
|
Bellevue Asset Management (UK) Ltd. |
|
Mark Ghahramani |
|
Telephone: +44 (0) 203 326 2981 |
|
|
|
J.P. Morgan Cazenove |
|
James Bouverat (Sales) |
|
Telephone: +44 (0) 207 134 2224 |
|
|
|
NSM Funds (UK) Limited |
|
Brian Smith, Ciara McKillop |
|
Telephone: +44 (0)20 3697 5770 |
|
1 Year Bellevue Healthcare Chart |
1 Month Bellevue Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions